Generation of a human induced pluripotent stem cell line (ZZUNEUi040-A) from a male patient with hypertrophic cardiomyopathy carrying a heterozygous TPM1 (c.644C > T) mutation
Authors:
- Jianchao ZhangJZJianchao Zhang
- Rencai PengRPRencai Peng
- Ningyu DingNDNingyu Ding
- Xiaowei LiXLXiaowei Li
Open Access
- 3 October 2026
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 97
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82000352)
- China Postdoctoral Science Foundation (2020M672295)
This publication has 5 references indexed in Scilit:
- Mechanisms and Therapies of Hypertrophic CardiomyopathyAnnual Review of Physiology, 2026
- Hypertrophic cardiomyopathyNature Reviews Disease Primers, 2025
- Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy–associated TPM1 variantsJournal of Clinical Investigation, 2024
- Molecular Genetic Basis of Hypertrophic CardiomyopathyCirculation Research, 2021
- Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation CarriersJACC, 2020